A detailed history of New York State Common Retirement Fund transactions in Cor Medix Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 11,163 shares of CRMD stock, worth $115,313. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,163
Previous 18,063 38.2%
Holding current value
$115,313
Previous $78,000 15.38%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$3.64 - $8.23 $25,116 - $56,787
-6,900 Reduced 38.2%
11,163 $90,000
Q2 2024

Jul 31, 2024

BUY
$4.08 - $6.39 $130 - $204
32 Added 0.18%
18,063 $78,000
Q4 2023

Feb 01, 2024

SELL
$3.0 - $4.01 $357 - $477
-119 Reduced 0.66%
18,031 $68,000
Q3 2023

Nov 07, 2023

BUY
$3.6 - $4.46 $1,980 - $2,453
550 Added 3.13%
18,150 $67,000
Q2 2023

Aug 07, 2023

BUY
$3.94 - $5.8 $69,344 - $102,080
17,600 New
17,600 $70,000
Q2 2022

Aug 04, 2022

SELL
$2.73 - $5.61 $63,472 - $130,432
-23,250 Reduced 98.86%
268 $1,000
Q4 2021

Feb 02, 2022

SELL
$4.47 - $5.56 $281 - $350
-63 Reduced 0.27%
23,518 $107,000
Q3 2021

Nov 02, 2021

BUY
$4.46 - $7.11 $521 - $831
117 Added 0.5%
23,581 $110,000
Q2 2021

Aug 02, 2021

BUY
$6.05 - $10.09 $1,597 - $2,663
264 Added 1.14%
23,464 $161,000
Q1 2021

May 11, 2021

BUY
$6.84 - $17.58 $12,312 - $31,643
1,800 Added 8.41%
23,200 $232,000
Q4 2020

Feb 08, 2021

BUY
$5.0 - $9.15 $34,000 - $62,220
6,800 Added 46.58%
21,400 $159,000
Q4 2019

Feb 05, 2020

SELL
$4.96 - $7.75 $47,120 - $73,625
-9,500 Reduced 39.42%
14,600 $106,000
Q2 2019

Aug 09, 2019

BUY
$5.93 - $10.57 $142,913 - $254,737
24,100 New
24,100 $216,000

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $426M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.